Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Phase 2: to determine whether the addition of ABT-414 to concomitant radiotherapy and temozolomide prolongs progression free survival (PFS) in subjects with newly diagnosed GBM harboring EGFR amplificaton. Phase 3: to determine whether the addition of ABT-414 to concomitant radiotherapy and temozolomide prolongs overall survival (OS) in subjects with newly diagnosed GBM harboring EGFR amplificaton
Critère d'inclusion
- Newly diagnosed glioblastoma (GBM) or gliosarcoma